Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management
- PMID: 30838070
- PMCID: PMC6376438
- DOI: 10.1302/1863-2548.13.180190
Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management
Abstract
The majority of patients with osteogenesis imperfecta (OI) have mutations in the COL1A1 or COL1A2 gene, which has consequences for the composition of the bone matrix and bone architecture. The mutations result in overmodified collagen molecules, thinner collagen fibres and hypermineralization of bone tissue at a bone matrix level. Trabecular bone in OI is characterized by a lower trabecular number and connectivity as well as a lower trabecular thickness and volumetric bone mass. Cortical bone shows a decreased cortical thickness with less mechanical anisotropy and an increased pore percentage as a result of increased osteocyte lacunae and vascular porosity. Most OI patients have mutations at different locations in the COL1 gene. Disease severity in OI is probably partly determined by the nature of the primary collagen defect and its location with respect to the C-terminus of the collagen protein. The overall bone biomechanics result in a relatively weak and brittle structure. Since this is a result of all of the above-mentioned factors as well as their interactions, there is considerable variation between patients, and accurate prediction on bone strength in the individual patient with OI is difficult. Current treatment of OI focuses on adequate vitamin-D levels and interventions in the bone turnover cycle with bisphosphonates. Bisphosphonates increase bone mineral density, but the evidence on improvement of clinical status remains limited. Effects of newer drugs such as antibodies against RANKL and sclerostin are currently under investigation. This paper was written under the guidance of the Study Group Genetics and Metabolic Diseases of the European Paediatric Orthopaedic Society.
Keywords: bisphosphonates; collagen I; fracture; hypermineralization; osteogenesis imperfecta.
Figures
Similar articles
-
Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.J Bone Miner Res. 2017 Sep;32(9):1884-1892. doi: 10.1002/jbmr.3180. Epub 2017 Jun 26. J Bone Miner Res. 2017. PMID: 28548288 Free PMC article. Clinical Trial.
-
Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.Osteoporos Int. 2016 Nov;27(11):3331-3341. doi: 10.1007/s00198-016-3653-0. Epub 2016 Jun 2. Osteoporos Int. 2016. PMID: 27256333
-
Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.Bone. 2015 Feb;71:115-23. doi: 10.1016/j.bone.2014.10.012. Epub 2014 Oct 23. Bone. 2015. PMID: 25445450 Free PMC article.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
-
Management of Osteogenesis Imperfecta.Front Endocrinol (Lausanne). 2020 Feb 11;10:924. doi: 10.3389/fendo.2019.00924. eCollection 2019. Front Endocrinol (Lausanne). 2020. PMID: 32117044 Free PMC article. Review.
Cited by
-
Osteoclast indices in osteogenesis imperfecta: systematic review and meta-analysis.JBMR Plus. 2024 Aug 21;8(11):ziae112. doi: 10.1093/jbmrpl/ziae112. eCollection 2024 Nov. JBMR Plus. 2024. PMID: 39372603 Free PMC article.
-
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Sep 4. doi: 10.1007/s00223-024-01263-8. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39231826 Review.
-
Matrix first, minerals later: fine-tuned dietary phosphate increases bone formation in zebrafish.JBMR Plus. 2024 Jun 18;8(8):ziae081. doi: 10.1093/jbmrpl/ziae081. eCollection 2024 Aug. JBMR Plus. 2024. PMID: 39045128 Free PMC article.
-
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.J Bone Miner Res. 2024 Sep 2;39(9):1215-1228. doi: 10.1093/jbmr/zjae112. J Bone Miner Res. 2024. PMID: 39012717 Free PMC article. Clinical Trial.
-
A review of the current state of natural biomaterials in wound healing applications.Front Bioeng Biotechnol. 2024 Mar 27;12:1309541. doi: 10.3389/fbioe.2024.1309541. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38600945 Free PMC article. Review.
References
-
- Kivirikko KI. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med 1993;25:113-126. - PubMed
-
- Byers PH, Steiner RD. Osteogenesis imperfecta. Annu Rev Med 1992;43:269-282. - PubMed
-
- Prockop DJ. Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. J Biol Chem 1990;265:15349-15352. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
